Current Oncology (May 2024)

Opioids and Cancer: Current Understanding and Clinical Considerations

  • Dhananjay Sah,
  • Hagit Shoffel-Havakuk,
  • Nir Tsur,
  • Megan L. Uhelski,
  • Vijaya Gottumukkala,
  • Juan P. Cata

DOI
https://doi.org/10.3390/curroncol31060235
Journal volume & issue
Vol. 31, no. 6
pp. 3086 – 3098

Abstract

Read online

Pain is one of the most common symptoms in patients with cancer. Pain not only negatively affects the quality of life of patients with cancer, but it has also been associated with reduced survival. Pain management is therefore a critical component of cancer care. Prescription opioids remain the first-line approach for the management of moderate-to-severe pain associated with cancer. However, there has been increasing interest in understanding whether these analgesics could impact cancer progression. Furthermore, epidemiological data link a possible association between prescription opioid usage and cancer development. Until more robust evidence is available, patients with cancer with moderate-to-severe pain may receive opioids to decrease suffering. However, future studies should be conducted to evaluate the role of opioids and opioid receptors in specific cancers.

Keywords